PT  - JOURNAL ARTICLE
AU  - Michael G. Tyshenko
AU  - Tamer Oraby
AU  - Joseph Longenecker
AU  - Harri Vainio
AU  - Janvier Gasana
AU  - Walid Q. Alali
AU  - Mohammad AlSeaidan
AU  - Susie Elsaadany
AU  - Mustafa Al-Zoughool
TI  - Analysis of Intervention Effectiveness Using Early Outbreak Transmission Dynamics to Guide Future Pandemic Management and Decision-Making in Kuwait
AID  - 10.1101/2021.01.07.21249409
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.07.21249409
4099  - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249409.short
4100  - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249409.full
AB  - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a World Health Organization designated pandemic that can result in severe symptoms and death that disproportionately affects older patients or those with comorbidities. Kuwait reported its first imported cases of COVID-19 on February 24, 2020. Analysis of data from the first three months of community transmission of the COVID-19 outbreak in Kuwait can provide important guidance for decision-making when dealing with future SARS-CoV-2 epidemic wave management. The analysis of intervention scenarios can help to evaluate the possible impacts of various outbreak control measures going forward which aim to reduce the effective reproduction number during the initial outbreak wave. Herein we use a modified susceptible-exposed-asymptomatic-infectious-removed (SEAIR) transmission model to estimate the outbreak dynamics of SARS-CoV-2 transmission in Kuwait. We fit case data from the first 96 days in the model to estimate the basic reproduction number and used Google mobility data to refine community contact matrices. The SEAIR modelled scenarios allow for the analysis of various interventions to determine their effectiveness. The model can help inform future pandemic wave management, not only in Kuwait but for other countries as well.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Kuwait Institute for Advancement of Science (KFAS) grant number CORONA-46 to Dr. Al-Zoughool.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesContact Dr. Mustafa Al-Zoughool regarding the availability of data referred to in the manuscript